MedTrace Logo

The Effect of Maternal Iron Deficiency Anemia on Fetal Hemodynamic and Neonatal Outcome

NCT04016922 · Status: UNKNOWN · Type: OBSERVATIONAL · Enrollment: 500

Last updated 2019-07-16

No results posted yet for this study

Summary

This study will be conducted to show the effect of different degrees of maternal iron deficiency anemia on fetal hemodynamics and neonatal outcome and to evaluate the effect of treatment.

Conditions

  • Fetal Conditions

Interventions

OTHER

Oral ferrous fumerate for Group A, Parenteral iron sucrose for Group B, Compatible blood transfusion for Group C

Consent, history. US: fetal heart activity, placental site, fetal biometry, AFI, anomalies, Doppler: umbilical artery, MCA, fetal renal artery, C\\U ratio. \* Maternal Hb,US at time of first visit, 10 days later after initiation of treatment, at EDD . * As part of routine medical care of these patients, they are managed as: A: give oral iron in the form of ferrous fumerate with the possible side effects. if Hb returns to normal, continue iron for 3 mon. B: admit to receive IV iron sucrose according to product literature allergic reaction may happen; antiallergic measures. C: give blood transfusion in the form of packed RBC. allergic and pyrogenic reaction and infection may occur. At delivery will be subjected to: examination, investigations, US.

Sponsors & Collaborators

  • Cairo University

    lead OTHER

Principal Investigators

  • Muhamad Ehab, professor · Cairo University

Eligibility

Min Age
20 Years
Max Age
35 Years
Sex
FEMALE
Healthy Volunteers
No

Timeline & Regulatory

Start
2019-07-31
Primary Completion
2019-10-31
Completion
2019-10-31

Countries

  • Egypt

Study Locations

More Related Trials

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT04016922 on ClinicalTrials.gov